Pharma Pulse

Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more

ByMiranda Schmalfuhs

May 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more

ByMiranda Schmalfuhs

April 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/29/24: Going Beyond Visuals to Connect with Diverse Audiences, Invensify Introduces Energy Efficient Cold Chain Shipping Transporter & more

ByMiranda Schmalfuhs

April 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

ByMiranda Schmalfuhs

April 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

ByMiranda Schmalfuhs

April 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/23/24: Meta Places Smart Assistants Across Its Apps, Burden of Pneumococcal Disease Consistent Across Age Groups & more

ByMiranda Schmalfuhs

April 23rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more

ByMiranda Schmalfuhs

April 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

ByMiranda Schmalfuhs

April 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more

ByMiranda Schmalfuhs

April 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

ByMiranda Schmalfuhs

April 17th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

ByMiranda Schmalfuhs

April 16th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

ByMiranda Schmalfuhs

April 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

ByMiranda Schmalfuhs

April 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

ByMiranda Schmalfuhs

April 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

ByMiranda Schmalfuhs

April 10th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more

ByMiranda Schmalfuhs

April 9th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

ByMiranda Schmalfuhs

April 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

ByMiranda Schmalfuhs

April 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

ByMiranda Schmalfuhs

April 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

ByMiranda Schmalfuhs

April 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

ByMiranda Schmalfuhs

April 2nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

ByMiranda Schmalfuhs

April 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

ByMiranda Schmalfuhs

March 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more

ByMiranda Schmalfuhs

March 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more

ByMiranda Schmalfuhs

March 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/26/24: Medicare to Cover Wegovy, US-China Decoupling Poses Supply Chain Risks & more

ByMiranda Schmalfuhs

March 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/25/24: The Intersection of AI & Marketing, Birth Control to Be Sold OTC & more

ByMiranda Schmalfuhs

March 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/22/24: More Studies by Columbia Cancer Researches Retracted, Vista.ai Appoints MedTech Veteran as CEO & more

ByMiranda Schmalfuhs

March 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more

ByMiranda Schmalfuhs

March 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more

ByMiranda Schmalfuhs

March 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse

Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more

Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more

Pharma Pulse 4/29/24: Going Beyond Visuals to Connect with Diverse Audiences, Invensify Introduces Energy Efficient Cold Chain Shipping Transporter & more

Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more

Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more

Pharma Pulse 4/23/24: Meta Places Smart Assistants Across Its Apps, Burden of Pneumococcal Disease Consistent Across Age Groups & more

Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more

Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more

Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more

Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more

Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more

Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more

Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more

Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more

Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more

Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more

Pharma Pulse 3/26/24: Medicare to Cover Wegovy, US-China Decoupling Poses Supply Chain Risks & more

Pharma Pulse 3/25/24: The Intersection of AI & Marketing, Birth Control to Be Sold OTC & more

Pharma Pulse 3/22/24: More Studies by Columbia Cancer Researches Retracted, Vista.ai Appoints MedTech Veteran as CEO & more

Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more

Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more

Trending on Pharmaceutical Commerce

BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery

The Hidden Economics of Health Insurance Affordability

Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning

Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts

Dawsongroup tcs USA Launches in the States